Supercharge site selection and feasibility with AI digital twins of every research site on the planet

Ryght AI's generative AI platform enables sponsors and CROs to quickly find, select, and activate the best sites for their study protocols — and continuously optimize site performance after activation.

BOOK DEMO SEE RYGHT IN ACTION
Group 2334
Traditional Site Selection Methods Illustration
THE PROBLEM

Traditional site selection and feasibility methods are outdated, inefficient and expensive

Sponsors and CROs are still relying on outdated spreadsheets of disparate data to evaluate sites, and assessing feasibility is plagued by guesswork and slow response times.

THE SOLUTION

Identify the best sites, activate faster and start enrollment sooner

Ryght AI rapidly analyzes your protocol and then instantly connects you with high-potential research sites—anywhere in the world.

Our technology streamlines site selection, accelerates activation, gets your studies enrolling patients sooner than traditional approaches, then optimizes site performance for the duration of the trial.

TEST RYGHT ON AN OLD PROTOCOL
AI Match Clinical Research Sites to Protocol
AI TWIN TECHNOLOGY

What is an AI digital twin?

AI digital twins are virtual replicas of real-world entities that allows users to monitor, analyze, and predict the performance of the physical entity it represents. 

By creating virtual replicas of every clinical research site in the world, Ryght's AI-powered platform supplements sponsors' own "private twin" data with Ryght's comprehensive "public twins", providing powerful predictive capabilities that enhance study startup, recruitment and enrollment.

Group 2296

Ingest + Analyze

Leverage advanced AI and machine learning algorithms to analyze complex datasets and identify patterns in seconds. 

Group 2297

Simulate + Forecast

Run potential scenarios to predict enrollment performance and anticipate potential issues or opportunities

Group 2299

Dynamic + Interactive

Every twin is constantly updated by AI retriever agents with real-time data from public and other sources, reflecting changes in the physical world. 

Group 2298

Optimize + Adapt

Adjust protocol parameters in real-time based on emerging data, leading to more efficient and successful trials. 

AI TWINS

A complete, dynamic data-derived replica of every clinical research site on the planet

 

Digital AI Twin of Research Sites - Layers of Data 1
Digital AI Twin of Research Sites - Layers of Data 2
AI TWINS

A complete, dynamic data-derived replica of every clinical research site on the planet

Ryght Platform - AI Digital Twins of Research Sites
POWERFUL SOLUTIONS

Explore the Ryght platform

RYGHT AI Platform for CROs
 NETWORK NAVIGATOR

Leverage AI-powered digital twins to instantly analyze every research site around the globe and reveal the locations that best match your protocol’s needs. 

LEARN MORE
Ryght AI Feasibility Accelerator
 FEASIBILITY ACCELERATOR

Automatically send qualified sites pre-populated feasibility questionnaires powered by data from our AI digital twin network. Track and compare all responses in real-time.

LEARN MORE

Available on the Microsoft Azure Marketplace

Ryght is available on Microsoft Azure Marketplace, making it easy for sponsors and CROs to use existing cloud commitments, simplify billing, and increase cost efficiency.

VIEW RYGHT ON AZURE MARKETPLACE
Screenshot 2025-07-21 at 12.21.22 PM
PUT RYGHT TO THE TEST

Discover the difference AI-powered site selection and feasibility can make.

We understand why you might be skeptical, which is why we’re ready to demonstrate Ryght’s capabilities for you in real time. 

Just give us twenty minutes and an old protocol, and we'll show you how quickly Ryght finds the best-fit sites for your trial before you finish your coffee. 
TESTIMONIALS

Trusted by top healthcare and research companies worldwide

"By streamlining study selection, feasibility, and patient referrals, the Ryght Research Network will allow us to focus more on advancing patient care and less on administrative burden while running the trials that are most likely to succeed."

M.D, Ph.D., Associate Dean of Clinical Research, Keck School of Medicine of the University of Southern California DAVID FRIEDLAND

"Ryght Al's unique and powerful platform streamlines clinical trials from site selection to activation nd enrollment, ultimately speeding up time to market for our biopharma clients."

Executive Vice President and Global Head of Clinical Research, QPS DEREK GRIMES

"At the University of Adelaide, we are committed to advancing world-class research that addresses many of the challenges faced by society. By working together, we can leverage our collective expertise to develop innovative, responsible and tested solutions for better public health and other critical issues and bring Australia's Al capabilities up to world-class standards where they belong."

Director of the Institute for Photonics and Advanced Sensing (IPAS)Adelaide University PROFESSOR MARK HUTCHINSON, PhD
KEEP UP WITH RYGHT

Stay Connected

Subscribe to be the first to know about product updates, news and announcements.